As regulatory bodies like the FDA move to reduce reliance on animal testing, the drug development landscape is undergoing a major transformation. New Approach Methodologies (NAMs), including advanced in vitro systems and computational tools, are reshaping how we study disease, identify targets and evaluate drug safety. At the forefront of this shift are human induced pluripotent stem cell (iPSC)-derived models, offering unprecedented insights into human biology.
This summit explores how iPSC-based NAMs are bridging the translational gap between preclinical research and clinical relevance. Attendees will gain a comprehensive understanding of how these models are accelerating the path from discovery to IND filing.
Whether you're new to iPSC applications or an experienced researcher, this event delivers actionable insights and expert-led case studies to support your work across the drug development pipeline.
Join us to:
- Explore real-world implementations of iPSC-derived systems
- Understand evolving regulatory expectations around NAMs
- Discover cutting-edge strategies for integrating iPSCs into modern biomedical workflows
Be part of the future of drug discovery—reserve your spot today and help lead the shift toward more human-relevant science.
Date: September 24th, 2025
Time: 2:00-6:00pm (Check-in to begin at 1:30pm)
Location: South San Francisco (Details provided upon registration)
Networking, posters, food and drink to follow.
Related Products & Solutions
-
High-Content Analysis Software
Intuitive software solutions for advanced results.
-
High-Content Analysis Systems
Utilizing powerful software, high-content analysis (HCA) systems address a wide range of research applications from basic science to complex compound screening.